Last updated on January 2020

A Study of LY3437943 in Participants With Type 2 Diabetes Mellitus (T2DM)


Brief description of study

The main purpose of this study is to learn about the side effects of LY3437943 when given to participants with type 2 diabetes. Blood tests will be performed to investigate how the body processes the study drug and how the study drug affects the body. Each enrolled participant will receive injections of LY3437943, dulaglutide, or placebo given just under the skin. For each participant, the study will last up to about 5 months and will include 16 visits to the study center.

Clinical Study Identifier: NCT04143802

Find a site near you

Start Over

PRA Health Sciences

Lenexa, KS United States
  Connect »